ACIU Stock Discussion

AC Immune SA Description

AC Immune Ltd is a Switzerland-based company engaged in the medical biotechnology sector. It develops treatments for Alzheimer’s and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinson's, and focuses on producing therapeutic and diagnostic product candidates, using SupraAntigen and Morphomer technology platforms. The Company's pipeline includes Crenezumab, ACI-24, Anti-Tau antibody, Morphomer Tau, Tau-PET imaging agent, Morphomer Abeta and Morphomer alpha-syn, among others.

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Organ Systems Imaging Alzheimer's Disease Parkinson's Disease Neurological Disorders Neurodegenerative Diseases Dementia Psychiatric Diagnosis Glaucoma Degenerative Disease Neurodegeneration Imaging Agent Amyloid Beta Company's Pipeline